These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 26912566)

  • 1. Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis.
    Ponsoye M; Frantz C; Ruzehaji N; Nicco C; Elhai M; Ruiz B; Cauvet A; Pezet S; Brandely ML; Batteux F; Allanore Y; Avouac J
    Ann Rheum Dis; 2016 Dec; 75(12):2142-2149. PubMed ID: 26912566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis.
    Desallais L; Avouac J; Fréchet M; Elhai M; Ratsimandresy R; Montes M; Mouhsine H; Do H; Zagury JF; Allanore Y
    Arthritis Res Ther; 2014 Jul; 16(4):R157. PubMed ID: 25059342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis.
    Akhmetshina A; Venalis P; Dees C; Busch N; Zwerina J; Schett G; Distler O; Distler JH
    Arthritis Rheum; 2009 Jan; 60(1):219-24. PubMed ID: 19116940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis.
    Huang J; Beyer C; Palumbo-Zerr K; Zhang Y; Ramming A; Distler A; Gelse K; Distler O; Schett G; Wollin L; Distler JH
    Ann Rheum Dis; 2016 May; 75(5):883-90. PubMed ID: 25858641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of phosphodiesterase 4 (PDE4) reduces dermal fibrosis by interfering with the release of interleukin-6 from M2 macrophages.
    Maier C; Ramming A; Bergmann C; Weinkam R; Kittan N; Schett G; Distler JHW; Beyer C
    Ann Rheum Dis; 2017 Jun; 76(6):1133-1141. PubMed ID: 28209630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of the transcription factor STAT-4 prevents inflammation-driven fibrosis in animal models of systemic sclerosis.
    Avouac J; Fürnrohr BG; Tomcik M; Palumbo K; Zerr P; Horn A; Dees C; Akhmetshina A; Beyer C; Distler O; Schett G; Allanore Y; Distler JH
    Arthritis Rheum; 2011 Mar; 63(3):800-9. PubMed ID: 21360510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Costimulatory Pathways in Systemic Sclerosis.
    Boleto G; Allanore Y; Avouac J
    Front Immunol; 2018; 9():2998. PubMed ID: 30619351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role of the adhesion receptor DNAX accessory molecule-1 (DNAM-1) in the development of inflammation-driven dermal fibrosis in a mouse model of systemic sclerosis.
    Avouac J; Elhai M; Tomcik M; Ruiz B; Friese M; Piedavent M; Colonna M; Bernhardt G; Kahan A; Chiocchia G; Distler JH; Allanore Y
    Ann Rheum Dis; 2013 Jun; 72(6):1089-98. PubMed ID: 23161903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The specific free radical scavenger edaravone suppresses fibrosis in the bleomycin-induced and tight skin mouse models of systemic sclerosis.
    Yoshizaki A; Yanaba K; Ogawa A; Iwata Y; Ogawa F; Takenaka M; Shimizu K; Asano Y; Kadono T; Sato S
    Arthritis Rheum; 2011 Oct; 63(10):3086-97. PubMed ID: 21618208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined inhibition of IL-1, IL-33 and IL-36 signalling by targeting IL1RAP ameliorates skin and lung fibrosis in preclinical models of systemic sclerosis.
    Grönberg C; Rattik S; Tran-Manh C; Zhou X; Rius Rigau A; Li YN; Györfi AH; Dickel N; Kunz M; Kreuter A; Matei EA; Zhu H; Skoog P; Liberg D; Distler JH; Trinh-Minh T
    Ann Rheum Dis; 2024 Aug; 83(9):1156-1168. PubMed ID: 38594058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis.
    Yoshizaki A; Yanaba K; Yoshizaki A; Iwata Y; Komura K; Ogawa F; Takenaka M; Shimizu K; Asano Y; Hasegawa M; Fujimoto M; Sato S
    Arthritis Rheum; 2010 Aug; 62(8):2476-87. PubMed ID: 20506342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
    Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
    Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosis.
    Takahashi T; Asano Y; Ichimura Y; Toyama T; Taniguchi T; Noda S; Akamata K; Tada Y; Sugaya M; Kadono T; Sato S
    Arthritis Rheumatol; 2015 Jan; 67(1):254-65. PubMed ID: 25302613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of pregnane X receptor inhibits experimental dermal fibrosis.
    Beyer C; Skapenko A; Distler A; Dees C; Reichert H; Munoz L; Leipe J; Schulze-Koops H; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2013 Apr; 72(4):621-5. PubMed ID: 23291432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis.
    Beyer C; Reich N; Schindler SC; Akhmetshina A; Dees C; Tomcik M; Hirth-Dietrich C; von Degenfeld G; Sandner P; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2012 Jun; 71(6):1019-26. PubMed ID: 22294631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological inhibition of porcupine induces regression of experimental skin fibrosis by targeting Wnt signalling.
    Chen CW; Beyer C; Liu J; Maier C; Li C; Trinh-Minh T; Xu X; Cole SH; Hsieh MH; Ng N; Althage A; Meeusen S; Pan S; Svensson EC; Seidel HM; Schett G; Gergely P; Harris JL; Distler JH
    Ann Rheum Dis; 2017 Apr; 76(4):773-778. PubMed ID: 28153829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis.
    Castelino FV; Bain G; Pace VA; Black KE; George L; Probst CK; Goulet L; Lafyatis R; Tager AM
    Arthritis Rheumatol; 2016 Dec; 68(12):2964-2974. PubMed ID: 27390295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CX3CL1 (fractalkine) monoclonal antibody attenuates lung and skin fibrosis in sclerodermatous graft-versus-host disease mouse model.
    Hasegawa T; Utsunomiya A; Chino T; Kasamatsu H; Shimizu T; Matsushita T; Obara T; Ishii N; Ogasawara H; Ikeda W; Imai T; Oyama N; Hasegawa M
    Arthritis Res Ther; 2024 May; 26(1):94. PubMed ID: 38702742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of hedgehog signalling prevents experimental fibrosis and induces regression of established fibrosis.
    Horn A; Kireva T; Palumbo-Zerr K; Dees C; Tomcik M; Cordazzo C; Zerr P; Akhmetshina A; Ruat M; Distler O; Beyer C; Schett G; Distler JH
    Ann Rheum Dis; 2012 May; 71(5):785-9. PubMed ID: 22402139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential roles of interleukin-17A in the development of skin fibrosis in mice.
    Okamoto Y; Hasegawa M; Matsushita T; Hamaguchi Y; Huu DL; Iwakura Y; Fujimoto M; Takehara K
    Arthritis Rheum; 2012 Nov; 64(11):3726-35. PubMed ID: 22833167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.